aTyr Pharma, Inc.ATYRNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+12.0%
5Y CAGR+28.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+12.0%/yr
vs +20.4%/yr prior
5Y CAGR
+28.3%/yr
Recent deceleration
Acceleration
-8.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $60.22M | +10.8% |
| 2024 | $54.37M | +28.6% |
| 2023 | $42.29M | -1.2% |
| 2022 | $42.81M | +84.0% |
| 2021 | $23.26M | +34.5% |
| 2020 | $17.29M | +23.1% |
| 2019 | $14.05M | -31.1% |
| 2018 | $20.39M | -32.2% |
| 2017 | $30.07M | -32.0% |
| 2016 | $44.25M | - |